目前，市场上有一些针对肝细胞生长因子受体和成纤维细胞生长因子受体的药物。
There are some very interesting agents on the market which will target hepatocyte growth factor receptor and fibroblast growth factor receptors.
表皮生长因子受体(EGFR)在人类肝细胞广泛表达，表皮生长因子可能是肝细胞生长中必须的有丝分裂原。
Epidermal growth factor receptor (EGFR) is frequently expressed in human hepatoma cells, and EGF may be one of the mitogens that are needed for the growth of hepatoma cells.
目的探讨肝细胞生长因子及其受体在胃癌组织中表达的意义。
Objective to investigate the role of expression of hepatocyte growth factor and its receptor in gastric cancer.
目的：比较表皮生长因子受体(EGFR)在肝细胞癌及胆管细胞癌中表达的差异。
Purpose to explore the difference in the expression of epidermal growth factor receptor (EGFR) between hepatocellular carcinoma and cholangiocarcinoma.
应用受体的放射配基结合分析法测定出甜菜碱对大鼠肝细胞膜表皮生长因子受体（EGF）及其酪氨酸蛋白激酶（TPK）有显著的结合抑制作用。
Using radioligand of binding assay of receptors determinates that betaine can inhibit the binding of EGF receptor with EGF and affect the TPK activity conspicuously.
应用受体的放射配基结合分析法测定出甜菜碱对大鼠肝细胞膜表皮生长因子受体（EGF）及其酪氨酸蛋白激酶（TPK）有显著的结合抑制作用。
Using radioligand of binding assay of receptors determinates that betaine can inhibit the binding of EGF receptor with EGF and affect the TPK activity conspicuously.
应用推荐